Adults over the age of sixty-five spend over twenty days per year obtaining health care
1. In this cross-sectional study, community-dwelling adults over the age of sixty-five averaged nearly twenty-one “health care contact days” per ...
Tag: internal medicine
Generic and brand-name fluticasone-salmeterol are equally effective in COPD management
1. In this cohort study, using generic versus brand-name fluticasone-salmeterol was associated with similar outcomes in chronic obstructive pulmonary disease ...
Concizumab reduces bleeding episodes in hemophilia patients with inhibitors
1. In this phase three open-label randomized trial, concizumab prophylaxis reduced the annualized bleeding rate in patients with hemophilia with ...
Inappropriate hospital admission as a risk factor for the subsequent development of adverse events
1. Patients with inappropriate hospital admission (IHA) experience twice more adverse events (AEs) on average than appropriately admitted patients. 2. ...
Dupilumab reduces the number exacerbations in patients with COPD and type two inflammation
1. In this randomized controlled trial, dupilumab use was associated with significantly fewer chronic obstructive pulmonary disease (COPD) exacerbations among ...
There is a low risk of chronic kidney disease progression following acute kidney injury
1. In this prospective cohort study, there was a limited association between acute kidney injury (AKI) and worsening kidney function ...
Adults with mpox have relatively low JYNNEOS vaccination rates
1. In this case-control study, adults with mpox were less likely to have been partially or fully vaccinated with the ...
Supervised hospital walking program reduces the need for nursing care
1. A supervised walking program was associated with reduced discharge rates to skilled-nursing facilities (SNF) from a Veterans Affairs (VA) ...
Hydrocortisone reduces mortality in severe community-acquired pneumonia
1. Among patients with severe community-acquired pneumonia (CAP) admitted to the intensive care unit (ICU), hydrocortisone reduced the risk of ...
Upadacitinib therapy effective at inducing remission in Crohn’s disease
1. In this randomized controlled trial, upadacitinib resulted in higher remission rates for patients with Crohn’s disease compared to a ...
